Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up
- 1.7k Downloads
To evaluate the short- and medium-term results of prostatic arterial embolisation (PAE) for benign prostatic hyperplasia (BPH).
This was a prospective non-randomised study including 255 patients diagnosed with BPH and moderate to severe lower urinary tract symptoms after failure of medical treatment for at least 6 months. The patients underwent PAE between March 2009 and April 2012. Technical success is when selective prostatic arterial embolisation is completed in at least one pelvic side. Clinical success was defined as improving symptoms and quality of life. Evaluation was performed before PAE and at 1, 3, 6 and every 6 months thereafter with the International Prostate Symptom Score (IPSS), quality of life (QoL), International Index of Erectile Function (IIEF), uroflowmetry, prostatic specific antigen (PSA) and volume. Non-spherical polyvinyl alcohol particles were used.
PAE was technically successful in 250 patients (97.9 %). Mean follow-up, in 238 patients, was 10 months (range 1–36). Cumulative rates of clinical success were 81.9 %, 80.7 %, 77.9 %, 75.2 %, 72.0 %, 72.0 %, 72.0 % and 72.0 % at 1, 3, 6, 12, 18, 24, 30 and 36 months, respectively. There was one major complication.
PAE is a procedure with good results for BPH patients with moderate to severe LUTS after failure of medical therapy.
• Prostatic artery embolisation offers minimally invasive therapy for benign prostatic hyperplasia.
• Prostatic artery embolisation is a challenging procedure because of vascular anatomical variations.
• PAE is a promising new technique that has shown good results.
KeywordsBenign prostatic hyperplasia Therapeutic embolization Prostatic diseases Angiography Catheterization
benign prostatic hyperplasia
prostatic artery embolisation
Conflict of interest
There is no funding or potential conflicts of interest for the authors regarding this article. The corresponding authors confirm that they have full access to all the data in this study and have final responsibility for the decision to submit for publication. All authors had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
- 4.McConnell JD, Bruskewitz R, Walsh P et al (1998) The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med 338:557–563PubMedCrossRefGoogle Scholar
- 19.Sapoval M, Daroles J, Rio Tinto H et al (2012) C-arm cone-beam CT in BPH: techniques and considerations for the safe treatment of benign prostatic hyperplasia. Endovascular Today April:61–63Google Scholar